Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Clinical trial NCT02507284 · COMPLETED
Trial details
- NCT number
- NCT02507284
- Sponsor
- Azevan Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-10
- Primary completion
- 2018-09-10
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.